metaLead Therapeutics (private company)

Switzerland
See something wrong or missing? Let us know
Offices:Zurich
Business model:B2B

metaLead is aq Swiss health startup developing a proprietary peptide-based therapeutic platform designed to identify and optimize short novel peptidic therapies targeting metal-related pathologies.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 1.07M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to metaLead Therapeutics

Name Criteria
Iceland 3Z Pharmaceuticals
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France ABC Transfer
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Athera
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden AttgeNO
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Denmark Oui
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Iceland geoSilica
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Gnosco
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Ilya Pharma
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain Origo Biopharma
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Pharmanest
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top